Effects of Digital Detox on Mental Health in Young Adults: A Randomized Controlled Trial

September 14, 2026 updated by: University of Bergen

The goal of this clinical trial is to learn whether a short, self-guided program for cutting down smartphone screen time can reduce symptoms of depression in young adults. It includes students in Oslo, Norway, who have applied for help at the student mental health service (SiO Mental Health).

The main questions it aims to answer are:

  • Does a 2-week screen time reduction program reduce symptoms of depression?
  • Does it reduce symptoms of anxiety?
  • Can a simple, widely available phone app reduce screen time, and does the reduction last?

Researchers will compare students who start the program right away with students who continue their usual care for 2 weeks and receive the same program afterwards. Participants are placed in one of the two groups by chance, like flipping a coin.

Participants will:

  • Answer questionnaires about depression and anxiety symptoms at the start and again after 2 weeks
  • Upload screenshots of the Screen Time summary on their iPhone at the start, after 2 weeks, and after 12 weeks
  • Install an app that blocks the apps they find most distracting and keep it active for 2 weeks, if they are placed in the program group
  • Take part entirely online, with no clinic visits and no contact with the study team

Study Overview

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Has applied for care at SiO Mental Health, the student mental health service in Oslo, and has received the service's response to the application
  • Owns an iPhone (the screen time restriction tool requires iOS)
  • Able to understand written Norwegian
  • Provides informed consent

Exclusion Criteria:

- None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Care as usual
Experimental: Screen time reduction
Two-week self-guided use of an iOS screen time restriction app. Participants block their most distracting apps, with notifications disabled. Unlocking requires a 30-second delay, allows 10 minutes of access, then a 5-minute cooldown.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptoms of depression (PHQ-9)
Time Frame: From enrollment to the end of intervention at 2 weeks
Patient Health Questionnaire-9, range 0 to 27, higher scores indicate more depressive symptoms.
From enrollment to the end of intervention at 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptoms of anxiety (GAD-7)
Time Frame: From enrollment to the end of intervention at 2 weeks
Generalized Anxiety Disorder-7, range 0 to 21, higher scores indicate more anxiety symptoms.
From enrollment to the end of intervention at 2 weeks
Total smartphone screen time
Time Frame: 2 weeks and 12 weeks after randomization
2 weeks and 12 weeks after randomization
Smartphone screen time by app category
Time Frame: 2 weeks and 12 weeks after randomization
2 weeks and 12 weeks after randomization
Number of daily smartphone pickups
Time Frame: 2 weeks and 12 weeks after randomization
2 weeks and 12 weeks after randomization

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported changes in sleep, physical activity, social interaction and concentration
Time Frame: 2 weeks
Single-item Likert-scale questions on perceived change in each domain during the 2-week period.
2 weeks
Self-reported changes in phone use behaviors
Time Frame: 2 weeks
Single-item Likert-scale questions on perceived change in phone use habits during the 2-week period.
2 weeks
Adherence to the screen time restriction tool
Time Frame: 2 weeks
Self-reported proportion of the 2-week period with the tool kept active, reported by the intervention group.
2 weeks
Perceived usefulness and burden of the tool
Time Frame: 2 weeks and 12 weeks
Self-reported usefulness, burden and intention to continue use, reported by the intervention group at 2 weeks and by both groups at 12 weeks.
2 weeks and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Mildestvedt, Professor, University of Bergen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 21, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

September 14, 2026

First Submitted That Met QC Criteria

September 14, 2026

First Posted (Actual)

September 18, 2026

Study Record Updates

Last Update Posted (Actual)

September 18, 2026

Last Update Submitted That Met QC Criteria

September 14, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 1000700

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized individual participant data underlying the published results.

IPD Sharing Time Frame

After publication of the primary results.

IPD Sharing Access Criteria

Upon request to the principal investigator, under a data sharing agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe